Involvement of Cdk5 activating subunit p35 in synaptic plasticity in excitatory and inhibitory neuronsMiyuki Takahashi, Toshio Ohshima, Takeru Nakabayashi et al.|Molecular Brain|2022Cited by 15
<i>De novo</i> non-synonymous DPYSL2 (CRMP2) variants in two patients with intellectual disabilities and documentation of functional relevance through zebrafish rescue and cellular transfection experimentsHisato Suzuki, Toshio Ohshima, Simo Li et al.|Human Molecular Genetics|2022Cited by 12
Lanthionine ketimine ester improves outcome in an MPTP-induced mouse model of Parkinson's disease via suppressions of CRMP2 phosphorylation and microglial activationKentaro Togashi, Toshio Ohshima, Arina Yazawa et al.|Journal of the Neurological Sciences|2020Cited by 10
Valproic acid downregulates Cdk5 activity via the transcription of the p35 mRNAMiyuki Takahashi, Shin‐ichi Hisanaga, Manami Ishida et al.|Biochemical and Biophysical Research Communications|2014Cited by 9
Valproic Acid-Induced Anxiety and Depression Behaviors are Ameliorated in p39 Cdk5 Activator-Deficient MiceMiyuki Takahashi, Shin‐ichi Hisanaga, Toshiyuki Takasugi et al.|Neurochemical Research|2022Cited by 8